Pathways for Optimal Sequencing, Rapid Initiation, and Titration of Therapy in Patients with Heart Failure
Upon completion of this activity, learners will be able to:
- Review the latest guidance on initiation and titration of therapies across classifications of HF by left ejection fraction
- Discuss unmet needs and clinical practice gaps stemming from sequential therapy initiation of HF therapies
- Create individualized HF treatment plans for optimal sequencing, rapid initiation, and titration of comprehensive disease-modifying medical therapy in eligible patients
Senior Dean of Faculty, Baylor College of Medicine
The Mary and Gordon Cain Chair and Professor of Medicine
Director, Winters Center for Heart Failure Research
Assoc. Director, Cardiovascular Research Institute
Baylor College of Medicine
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.
Completion of this activity, including the pretest, posttest, and follow-up assessments, qualifies as a medium weight MIPS improvement activity under MACRA and can be claimed as completion of IA_PSPA 28 of an Accredited Safety or Quality Improvement Program in the Quality Payment Program. Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website. You will receive additional information after completing the activity and receiving your certificate via email.